Member Info for hants

Parkez, no point him coming back at that point, bceause when AVCT have something to sell there won't be any posters left on this BB. Or any other lab based testing BBs, for that matter.

Somebody please correct me if I'm wrong, but I was under the impression there's currently no evidence the presence of antibodies guarantees you can't be reinfected and even if it does, for how long.

Some quick Googling brings up the following recent article, amongst others:

"Serological assays to detect SARS-CoV-2 antibodies are rapidly becoming available and will be critical to estimate the prevalence of infections, including those that are asymptomatic. However, it is presently premature to use such assays to determine whether individuals are immune to reinfection."

Of course, antibody tests are very useful to the Government for gathering statistics and tracking the spread. Without sounding too cynical, perhaps the Government are letting the public assume that having the antibodies means you are completely protected. That way, the public will be inclined to get tested, thus providing the stats which the Government need. Few people would be interested in getting testing if they didn't think a positive result meant they were definitely protected.

Just my ramblings. Interested to hear the thoughts of others.

It seems like this drop is on the Roche news?

I am genuinely concerned if there's people invested in Covid testing shares who don't understand the difference between an antibody test and an antigen test.

I had no intention of buying more, but just took some more at 109! Pleased with that!!

Cant even buy 100 shares on IG markets at present. Very odd.

Is Quidel really only 80%? That doesn't sound very good? I'll be dissapointed if the Avacta Affimer based tests are less than 95% and very dissapointed if they're less 90%. The language used so far indicates it should be pretty good, so I am hopeful of a positive outcome when Cytiva get the test working and publish some numbers.

If I had recently been somehwere there was a large number of people, whether that be shopping, gym, or even just to a friends house, whatever. Would I be confident to go and see my Grandmother if there was more than a 5%-10% chance of a false negative? Probably not.

The same applies if I had a PCR test result, from a swab I sent 2 days ago. If I had been somewhere busy in the 2 days previous, would I go and see my Grandmother? Again, probably not.

I would apply the same thought process to boarding a plane. if there's 150 people on that plane being screened with an accuracy of 80% before boarding, those odds are not good.

The need for an instant reliable test is massive. Not just for boarding planes, boats, going to work... but also just for normal day to day stuff like going to see family.

I hope one day soon we are all watching the briefing and the orange man mentions Cytiva and their 'new great american test.'

We'll know it's us, even if nobody else does.

I'm sure that day will be soon.

It's great waking up and seeing the new RNS icon! (Infact, I was treated to two RNS due to the ORPH news!)
Nice little gap up in the price. I feel the risk in Avacta is coming down whilst the potential is going up. If it takes until the middle of the summer as they're saying, I'll be surprised to be honest. Lateral Flow Tests aren't a new technology, and governments will be desperate to have this test approved and into manfacture. It's the only viable way out of the mess we are all in, unless somebody comes up with a vaccine out of the blue!

The iceing on the cake is the ability to detect the virus in it's development stage. Everytime I think my investment can't get better, somehow it does!

I bought my first tranches at 40p and have an average circa 50p, so have seen a nice return already with hopefully much more to go. Nothing top sliced. Holding tight.

PL75, you should win the award for best post of the weekend!

I agree with you. Lots of people at home Mojo.

Great RNS today. I'm particuarly interested in Salarius, I think that will be the big one.

Bought in this morning at 61.

I sold a few days ago thinking I could buy back cheaper and accumulate shares. Then Synairgen were on the TV and the share price rose quickly. I was not happy to have missed that!

I've been waiting for it to retrace and this morning has allowed me to get back in and also accumulate shares. I thought I had shot myself in the foot.

If it drops further, so be it. All these Covid shares are proving to be very news hungry (avct to a lesser extent).

Remember news can arrive anytime, as can an appearance on the news. I won't be attempting to trade up again, too risky. I am confident in Synairgen and I'm sure it will show good returns in the coming weeks.

The death rate in the UK is huge and all possible treatments are needed. I personally know two people who are currently on on ventilators and been for a fortnight, taken ill around the same time. One of these gentlemen no longer has COVID 19, he's fighting for his life because of the damage it's done to his body. His family tell me he can't even manage to speak.

Synairgen have a product which could save lives with COVID around, and also when its not longer around. Remember the treatment product was not developed for this purpose, it's just very 'fortunate' (poor word in the circumstances) timing.

Exactly Green23.

It could be like a high speed version of the landline/mobile phone scenario.

Do landlines still exist? Yes.
Do the general public use them much? No.

There's probably much better analogys than that, but its the best I can think of before my morning coffee.

I sold out of Genedrive at 62 before the rise so I missed out there - BUT I put the funds into Avacta, buying another tranche at 58 which has also made considerable ground, so I'm not upset at all.

Why did I do this? Well, I might be on by own here because I don't think anybody else has said it... but I think Avacta's product has the potential to put a serious dent in the share price of the companies offering tests which need a lab or equipment.

This could be compounded by the recent news that home based testing which involves swabbing could give a lot of false negatives if the swabbing isn't done correctly. Plus it's not a fun experience so a lot of the public probably won't be inclined to do it. I've already spoken to a few people who are dreading the idea of the swabbing, so not doubt there's many more. I'm not that keen on the idea myself if the person doing it isn't very good at it.

Yes, the overall market for testing is huge - but outside of hospitals I think the market for swab and lab based tests will be reduced significantly when saliva based testing of this type comes to market. My thoughts are based on the basic assumption these tests will be manufactured fast enough to meet demand and they are adequately accurate.

I've sold my ODX too. My worry was that I would see the share price of my AVCT going up, whilst simultaneously reversing the price of my other shares.

Discalimer: This is only my opinion and my own speculation.

It's now May, so I am expecting to see a gradual climb in aniticipation of news. Today's RNS, whilst not the one everybody has been waiting for, should inspire confidence.

HawkesBay - I don't know why people always seem to post that... I see it at least two or three times a week...

Don't know the reason for the rise over at SOLG, but bear in mind that GGP has around double the number of shares in issue as SOLG.

The third time we've seen this happen in the past couple of weeks. Doubt anybody is too fussed, I am certainly not. I'm sure many taking the opportunity to buy.

Another RNS or the CEO's next stop on his media roadshow and we'll be heading back up again.

If good news is anticipated as opposed to being unexpected, it can get priced in before the news formally arrives. When the news arrives, short term traders see it as the peak and hit the sell button.

GGP now looks like an even more solid investment for long term holders so I'm sure we'll start to see the more serious investors move in, and that should help to stabilise the price going forwards.

Do you mean Alastair?

He does look like a Graham, though.

I've just turned blue again on Orph. Has something happened?! Haven't been following it.

I was't panicked as I'm confident on my investment here - good prospects and they seem to be very keen on delivering results for the shareholders. Just nice to be out of the red!